SC 13D

Company

MAIA Biotechnology, Inc.

Filed

August 10, 2022

Accession Number

0001564590-22-028823

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →